CELSR1 and lymphedema: Moreover, in 2019, Maltese et al.21 reported that 5 of 95 probands carried novel loss-of-function variants in CELSR1. In 2021, Xia et al.22 reported that a CELSR1 deletion could be associated with lymphatic dysplasia in a lymphedema patient with 22q13.3 deletion syndrome.